Pharmacokinetic Study of E7080/Lenvatinib in Chinese Patients With Unresectable Hepatocellular Carcinoma (HCC)
Clinical trial NCT02953743 · COMPLETED
Trial details
- NCT number
- NCT02953743
- Sponsor
- Eisai Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-09-01
- Primary completion
- 2017-06-28
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.